Asthma Treatment With Add-On Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improved Lung Function and Asthma Control Compared With Placebo Plus High-Dose ICS

被引：0
|
作者：
Busse, William [1 ]
Castro, Mario [2 ]
Lugogo, Njira [3 ]
O'Byrne, Paul [4 ]
Bacharier, Leonard [5 ]
Xia, Changming [6 ]
Hardin, Megan [7 ]
Soliman, Mena [6 ]
Sacks, Harry [6 ]
Jacob-Nara, Juby [8 ]
Rowe, Paul [8 ]
Deniz, Yamo [6 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Kansas, Sch Med, Kansas City, KS USA
[3] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI USA
[4] McMaster Univ, Hamilton, ON, Canada
[5] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Med Ctr, Nashville, TN USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Cambridge, MA USA
[8] Sanofi, Bridgewater, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L23
引用
收藏
页码：AB368 / AB368
页数：1
相关论文
共 50 条
  • [21] Cochrane Corner: Addition of Long-Acting Beta2 Agonists or Long-Acting Muscarinic Antagonists Versus Doubling the Dose of Inhaled Corticosteroids (ICS) in Adolescents and Adults With Uncontrolled Asthma With Medium-Dose ICS
    Baigel, Rachel
    Gregory, Ian
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (09): : 647 - 650
  • [22] Effect of switching from high-dose inhaled corticosteroids (ICS) to low-dose ICS plus an inhaled long-acting B2-agonist on airway inflammatory cells and mediators and airway remodeling
    Dorinsky, PM
    Yancey, SY
    Rouse, P
    Emmett, A
    Boushey, H
    CHEST, 2003, 124 (04) : 86S - 87S
  • [23] Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA
    Inoue, Hiromasa
    Milligan, Ki Lee
    McConnon, Aine
    Yoshisue, Hajime
    Loefroth, Emil
    McSharry, Martin
    Yokoyama, Akihito
    Ichinose, Masakazu
    NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2021, 31 (01)
  • [24] Uncontrolled asthma: a retrospective cohort study in Japanese patients newly prescribed with medium-/high-dose ICS/LABA
    Hiromasa Inoue
    Ki Lee Milligan
    Aine McConnon
    Hajime Yoshisue
    Emil Loefroth
    Martin McSharry
    Akihito Yokoyama
    Masakazu Ichinose
    npj Primary Care Respiratory Medicine, 31
  • [25] ONCE-DAILY TIOTROPIUM RESPIMAT (R) ADD-ON TO ICS plus LABA IMPROVES SYMPTOM CONTROL AND REDUCES EXACERBATIONS IN PATIENTS WITH SYMPTOMATIC ASTHMA
    Price, D.
    Engel, M.
    Moroni-Zentgraf, P.
    Schmidt, H.
    Dahl, R.
    Paggiaro, P.
    Vandewalker, M.
    Kerstjens, H. A. M.
    Kaplan, A.
    THORAX, 2014, 69 : A49 - A50
  • [26] In uncontrolled asthma, adding a LAMA to ICS plus LABA improved lung function at 6 mo and reduced exacerbations at 1 y
    Stanbrook, Matthew B.
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (06) : JC28 - JC28
  • [27] Sub-optimal asthma control with medium- or high-dose ICS/LABA: a retrospective cohort study from Japan claims database
    Inoue, Hiromasa
    Milligan, Ki Lee
    Mcconnon, Aine
    Yoshisue, Hajime
    Loefroth, Emil
    Mcsharry, Martin
    Yokoyama, Akihito
    Ichinose, Masakazu
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [28] Lower ICS dose effect on symptoms and rescue medication use of indacaterol/glycopyrronium/mometasone (IND/GLY/MF) medium-dose vs salmeterol/fluticasone (Sal/Flu) high-dose plus tiotropium (Tio): ARGON study
    Gessner, Christian
    Kornmann, Oliver
    Maspero, Jorge
    Van Zyl-Smit, Richard
    Kruell, Matthias
    Sojo, Agustin
    Salina, Anna
    Gupta, Pritam
    Conde, Lorena Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] Significant percentage of asthma patients failed to achieve control in the first year after initiating medium or high dose ICS/LABA
    Cao, Hui
    Wilson, Andrew
    Loefroth, Emil
    Keininger, Dorothy
    Fogel, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [30] Safety and Tolerability of Medium and High Doses of Mometasone Furoate/Formoterol (MF/F) Combination Treatment, Administered Via a Metered-Dose Inhaler (MDI), in Severe Asthma Patients Previously Treated with High-Dose Inhaled Corticosteroids (ICS).
    Weinstein, S. F.
    White, M.
    Corren, J.
    Nolte, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
12345